- Home
- CR vs ASND Comparison
CR vs ASND Comparison
Compare CR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CR | ASND |
|---|---|---|
| Founded | 1855 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 12.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | CR | ASND |
|---|---|---|
| Price | $187.07 | $205.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 15 |
| Target Price | $223.60 | ★ $256.27 |
| AVG Volume (30 Days) | 333.5K | ★ 640.2K |
| Earning Date | 10-27-2025 | 11-12-2025 |
| Dividend Yield | ★ 0.49% | N/A |
| EPS Growth | ★ 37.96 | N/A |
| EPS | ★ 6.25 | N/A |
| Revenue | ★ $2,268,100,000.00 | $758,592,045.00 |
| Revenue This Year | $10.78 | $99.74 |
| Revenue Next Year | $13.09 | $79.40 |
| P/E Ratio | $34.33 | ★ N/A |
| Revenue Growth | 19.64 | ★ 97.46 |
| 52 Week Low | $127.04 | $118.03 |
| 52 Week High | $203.89 | $223.19 |
Technical Indicators
Market Signals| Indicator | CR | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 56.85 | 49.03 |
| Support Level | $179.46 | $198.30 |
| Resistance Level | $189.34 | $218.50 |
| Average True Range (ATR) | 4.28 | 9.16 |
| MACD | 0.73 | -0.64 |
| Stochastic Oscillator | 89.62 | 28.05 |
Price Performance
Historical ComparisonAbout CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.